Donnie Hardison

Donnie M.
Hardison is the founder of Dmh Consulting Group, LLC (2016).
Mr. Hardison is currently Vice Chairman at Bioporto A, Chairman at Geneoscopy, Inc., Independent Non-Executive Director at MDxHealth SA, Director at Stemina Biomarker Discovery, Inc., Director at YourBio Health, Inc., Director at Iquity Systems AB, Director at Episona, Inc., Director at Iquity, Inc., Director at Arima Genomics Inc. (2023), Director at Decode Health, Inc., Director at Breath Biomedical, Director at Bioporto Diagnostics A (2021), and Independent Director at Breathe BioMedical, Inc. (2022).
Former positions include President, Chief Executive Officer & Director at EXACT Sciences Corp.
(2000-2007), President, Chief Executive Officer & Director at Biotheranostics, Inc. (2017-2021), President, Chief Executive Officer & Director at Good Start Genetics, Inc. (2010-2016), Director at Valeo Medical, Inc., Independent Director at Cytek Biosciences, Inc. (2022-2025), Director at Predictive Biosciences, Inc., Independent Director at HTG Molecular Diagnostics, Inc. (2016-2023), Chief Operating Officer & Executive Vice President at Laboratory Corp.
of America Holdings (2007-2009), Partner at Siebel Systems, Inc., Senior Vice President-Sales & Marketing at Quest Diagnostics, Inc., Vice President-Sales & Marketing at GSK Plc, and Managing Partner at OnTarget,.
Inc. Education includes an undergraduate degree from the University of North Carolina at Chapel Hill.